+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The cross-talk between ROS and p38MAPKα in the Ex Vivo expanded human umbilical cord blood CD133(+) cells

The cross-talk between ROS and p38MAPKα in the Ex Vivo expanded human umbilical cord blood CD133(+) cells

Journal of Huazhong University of Science and Technology. Medical Sciences 31(5): 591

This study investigated the correlation between and compared the effects of reactive oxygen species (ROS) and p38 mitogen-activated protein kinase α (p38MAPKα) in the ex vivo expanded umbilical cord blood (hUCB) CD133(+) cells. hUCB CD133(+) cells were cultured in the hematopoietic stem cells (HSCs) culture medium with N-acetylcysteine (NAC, an anti-oxidant), p38MAPKα-specific inhibitor (SB203580) or their combination. The levels of ROS and expression of phosphorylated p38MAPKα (p-p38) in CD133(+) cells were flow cytometrically detected. The efficacy of ex vivo expansion was evaluated by the density of CD133(+) cell sub-group colony-forming cells (CFC) and cobblestone area-forming cells (CAFC) assay. Our results showed decreased ROS levels in NAC, SB203580, and their combination treatment groups were almost 37%, 48%, and 85%, respectively. Furthermore, SB203580 abrogated the activation of p38MAPKα more obviously than NAC. Moreover, the CD133(+) cells in SB203580 treatment group had a 21.93±1.36-fold increase, and 14.50±1.19-fold increase in NAC treatment group, but only 10.13±0.57-fold increase in control group. In addition, SB203580 treatment led a higher level increase in the number of CFU and CAFC than NAC did. These findings suggested that, in expanded CD133(+) cells, ROS activates p38MAPKα, which, in turn, induces ROS production, and p38MAPKα might be the most suitable regulator in ROS-p38MAPKα pathway for the promotion of HSCs ex vivo expansion.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 036246485

Download citation: RISBibTeXText

PMID: 22038345

DOI: 10.1007/s11596-011-0566-1

Related references

Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells. Stem Cells and Development 15(1): 70-78, 2006

Expanded CD133 + Cells from Human Umbilical Cord Blood Improved Heart Function in Rats after Severe Myocardial Infarction. Stem Cells International 2018: 5412478, 2018

Ex-vivo expanded human blood-derived CD133+ cells promote repair of injured spinal cord. Journal of the Neurological Sciences 328(1-2): 41-50, 2013

Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(3): 645-649, 2008

CD45+/CD133+ positive cells expanded from umbilical cord blood expressing PDX-1 and markers of pluripotency. Cell Biology International 34(8): 783-790, 2010

Human Application of Ex-Vivo Expanded Umbilical Cord-Derived Mesenchymal Stem Cells: Enhance Hematopoiesis after Cord Blood Transplantation. Cell Transplantation, 2013

Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: enhance hematopoiesis after cord blood transplantation. Cell Transplantation 22(11): 2041-2051, 2013

Homing Genes Expression in Fucosyltransferase VI-Treated Umbilical Cord Blood CD133+ Cells which Expanded on Protein-Coated Nanoscaffolds. Molecular Biotechnology 60(7): 455-467, 2018

Novel generation of cytokine induced killer cells from human umbilical cord blood expanded ex vivo with IL-15. Blood 94(10 Suppl. 1 Part 2): 55b, 1999

Engraftment of ex vivo expanded mononuclear cells from human umbilical cord blood in NOD/SCID mice. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15(6): 1243-1246, 2007

The Protein Content of Extracellular Vesicles Derived from Expanded Human Umbilical Cord Blood-Derived CD133 + and Human Bone Marrow-Derived Mesenchymal Stem Cells Partially Explains Why both Sources are Advantageous for Regenerative Medicine. Stem Cell Reviews and Reports 13(2): 244-257, 2017

Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Annals of Hematology 85(4): 212-225, 2006

Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo. CytoTherapy 12(1): 67-78, 2010

Cell cycle analysis of the CD133+ and CD133- cells isolated from umbilical cord blood. Clinica Chimica Acta; International Journal of Clinical Chemistry 343(1-2): 173-178, 2004

Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34⁺ cells in a murine model of umbilical cord blood transplantation. Blood Cells Molecules and Diseases 52(1): 59-67, 2014